Specific, isolated gene sequences can be very useful in research when their functions are known and easily obtained. Does this mean that researchers and scientists should be allowed to patent them if they are applicable to assist in real world, practical matter? The topic of gene patenting has been an ongoing controversy for a long period of time, and continues to be very controversial. Gene patenting leads to hindered research for all companies that do not own the patent and can slow down results for many medical matters. Patents lead to less competition between companies and possible investments in genetic sequences, however is not the most beneficial option to research in the present day, rapidly developing world. Both approaches to the argument of gene patenting are discussed and observed, along with the the positive and negative aspects of how it affects our expanding fields of research, medicine, and much more.